about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesStrategies and developments of immunotherapies in osteosarcomaBone microenvironment signals in osteosarcoma development.Advances in emerging drugs for osteosarcoma.Drugs in early clinical development for the treatment of osteosarcoma.Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.Novel molecular insights and new therapeutic strategies in osteosarcoma
P2860
Q26745742-9FB9F10E-0548-4E92-9FF5-59FD54346173Q36503128-695B4228-17C7-40EB-AC92-C071F093C558Q38454980-2DE256C2-EE07-45F1-A50D-B369F18F40A3Q38506118-84EA3067-6090-45A7-98AD-3C9AC459ED76Q38955517-9A5679D8-A799-426D-8F89-8EA5BF13E3E9Q42576424-B6AD6302-FAA4-40E1-A17D-6584B3FDF5E7Q57814118-661C1A06-F13B-4822-9551-6E7A82D35636
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genetically modified T-cell therapy for osteosarcoma
@ast
Genetically modified T-cell therapy for osteosarcoma
@en
type
label
Genetically modified T-cell therapy for osteosarcoma
@ast
Genetically modified T-cell therapy for osteosarcoma
@en
prefLabel
Genetically modified T-cell therapy for osteosarcoma
@ast
Genetically modified T-cell therapy for osteosarcoma
@en
P2860
P1476
Genetically modified T-cell therapy for osteosarcoma
@en
P2093
Christopher DeRenzo
Stephen Gottschalk
P2860
P304
P356
10.1007/978-3-319-04843-7_18
P407
P577
2014-01-01T00:00:00Z